Publication
Pre-symptomatic testing for neurodegenerative disorders: Middle- to long-term psychopathological impact: Pruebas pre-sintomáticas de enfermedades neurodegenerativas: el impacto psicopatológico a largo plazo
dc.contributor.author | Lêdo, Susana | |
dc.contributor.author | Leite, Ângela | |
dc.contributor.author | Souto, Teresa | |
dc.contributor.author | Dinis, Maria Alzira Pimenta | |
dc.contributor.author | Sequeiros, Jorge | |
dc.date.accessioned | 2019-09-13T12:59:41Z | |
dc.date.available | 2019-09-13T12:59:41Z | |
dc.date.issued | 2017-11 | |
dc.description | http://sherpa.ac.uk/romeo/issn/0214-9915/ | pt_PT |
dc.description.abstract | Background. Over the past 20 years, studies have revealed that the communication of a pre-symptomatic test (PST) result for autosomal dominant late-onset diseases, such as Huntington's disease (HD), doesn’t cause psychological disturbance. This cross-sectional study investigated the middle- (4 years) to long-term (7 and 10 years) psychological impact in individuals who agreed to perform the pre-symptomatic testing for 3 autosomal dominant late-onset diseases: HD, Machado-Joseph disease (MJD) and familial amyloid polyneuropathy (FAP). Method: The study included 203 subjects: 170 (84%) agreed to make the PST for FAP, 29 (14%) for HD and 4 (2%) for MJD. Subjects were mostly women (58%) and married (67%). Three cutoffs points were considered: 4 years (middle-term) and 7 and 10 years (long-term) indicating the time after receiving the PST results. Results: results showed that women and widows (oldest) participants presented the highest mean values for almost all BSI dimensions and the highest mean values correspond to the obsessive-compulsive BSI dimensions. Concerning the nature of the disease, MJD participants presented the highest mean values. No differences were found concerning the PST test results while participants are still asymptomatic. Psychopathology was only present in symptomatic carriers. Conclusions: The onset of the disease seems to assume the trigger for the presence of psychological disturbance in the subjects, regardless the time that has elapsed since the PST result communication or the individual carrier/non-carrier condition. | pt_PT |
dc.description.abstract | Antecedentes: el presente estudio transversal investigó el impacto psicopatológico a medio (4 años) y a largo plazo (7 y 10 años) de la prueba pre-sintomática (PPS) para tres enfermedades autosómicas dominantes de aparición tardía: enfermedad de Huntington EH, la enfermedad de Machado-Joseph (EMJ) y la polineuropatía amiloide familiar (PAF). Método: participaron 203 sujetos: 170 (84 %) realizaron el PPS para PAF, 29 (14 %) para EH y 4 (2 %) para EMJ. La muestra, en su mayoría, estuvo compuesta por mujeres (58 %) y por personas casadas (67 %). Fueron considerados como puntos de corte los 4, 7 y 10 años después de haber recibido el resultado de la PPS. Resultados: las mujeres y los viudos presentan las medias más altas. Los participantes con EMJ presentaron las medias más elevadas. No se encontraron diferencias significativas en lo concerniente a los resultados de PPS. La perturbación psicológica fue escasamente observada en los sujetos portadores que ya evidenciaban síntomas. Conclusiones: la aparición de los primeros síntomas parece constituir el detonante para la existencia de perturbaciones psicológicas, independientemente del intervalo de tiempo sucedido desde la comunicación de los resultados de la PPS o de la condición genética (portador/no portador). | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | APA: Lêdo, S., Leite, Â., Souto, T., Dinis, M. A. P., & Sequeiros, J. (2017). Pre-symptomatic testing for neurodegenerative disorders: Middle- to long-term psychopathological impact. Psicothema, 29(4), 446-452. doi:10.7334/psicothema2016.298 | pt_PT |
dc.identifier.doi | 10.7334/psicothema2016.298 | pt_PT |
dc.identifier.issn | 1886-144X | |
dc.identifier.uri | http://hdl.handle.net/10284/7857 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Colegio Oficial de Psicologos | pt_PT |
dc.relation.publisherversion | http://www.psicothema.com/psicothema.asp?ID=4419 | pt_PT |
dc.subject | Adult | pt_PT |
dc.subject | Aged | pt_PT |
dc.subject | Amyloid Neuropathies, Familial | pt_PT |
dc.subject | Asymptomatic Diseases | pt_PT |
dc.subject | Cross-Sectional Studies | pt_PT |
dc.subject | Female | pt_PT |
dc.subject | Humans | pt_PT |
dc.subject | Huntington Disease | pt_PT |
dc.subject | Machado-Joseph Disease | pt_PT |
dc.subject | Male | pt_PT |
dc.subject | Middle Aged | pt_PT |
dc.subject | Time Factors | pt_PT |
dc.subject | Young Adult | pt_PT |
dc.title | Pre-symptomatic testing for neurodegenerative disorders: Middle- to long-term psychopathological impact: Pruebas pre-sintomáticas de enfermedades neurodegenerativas: el impacto psicopatológico a largo plazo | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.endPage | 452 | pt_PT |
oaire.citation.issue | 4 | pt_PT |
oaire.citation.startPage | 446 | pt_PT |
oaire.citation.title | Psicothema | pt_PT |
oaire.citation.volume | 29 | pt_PT |
person.familyName | Lêdo | |
person.familyName | Dinis | |
person.familyName | Sequeiros | |
person.givenName | Susana | |
person.givenName | Maria Alzira Pimenta | |
person.givenName | Jorge | |
person.identifier | 493603 | |
person.identifier | 666710 | |
person.identifier.ciencia-id | 4710-147D-FDAF | |
person.identifier.ciencia-id | 0E17-D288-38BC | |
person.identifier.orcid | 0000-0003-3083-3129 | |
person.identifier.orcid | 0000-0002-2198-6740 | |
person.identifier.orcid | 0000-0002-9846-1037 | |
person.identifier.rid | F-3309-2011 | |
person.identifier.scopus-author-id | 55539804000 | |
person.identifier.scopus-author-id | 55851941438 | |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |
relation.isAuthorOfPublication | f114f5ce-d79b-44be-96b4-2ab1bf364d28 | |
relation.isAuthorOfPublication | 1e85592a-e8e2-4aea-bd8e-1007c94388c0 | |
relation.isAuthorOfPublication | 20b11e35-c7b6-4c50-933c-320b4cab674c | |
relation.isAuthorOfPublication.latestForDiscovery | 1e85592a-e8e2-4aea-bd8e-1007c94388c0 |